Literature DB >> 33579213

Wireless versus routine physiologic monitoring after cesarean delivery to reduce maternal morbidity and mortality in a resource-limited setting: protocol of type 2 hybrid effectiveness-implementation study.

Adeline A Boatin1,2,3,4, Joseph Ngonzi5, Blair J Wylie6,7, Henry M Lugobe5, Lisa M Bebell8,6,9, Godfrey Mugyenyi5, Sudi Mohamed5, Kenia Martinez5, Nicholas Musinguzi10, Christina Psaros6,11, Joshua P Metlay6,9, Jessica E Haberer8,6,9.   

Abstract

BACKGROUND: Women in sub-Saharan Africa have the highest rates of morbidity and mortality during childbirth globally. Despite increases in facility-based childbirth, gaps in quality of care at facilities have limited reductions in maternal deaths. Infrequent physiologic monitoring of women around childbirth is a major gap in care that leads to delays in life-saving interventions for women experiencing complications.
METHODS: We will conduct a type-2 hybrid effectiveness-implementation study over 12 months to evaluate using a wireless physiologic monitoring system to detect and alert clinicians of abnormal vital signs in women for 24 h after undergoing emergency cesarean delivery at a tertiary care facility in Uganda. We will provide physiologic data (heart rate, respiratory rate, temperature and blood pressure) to clinicians via a smartphone-based application with alert notifications if monitored women develop predefined abnormalities in monitored physiologic signs. We will alternate two-week intervention and control time periods where women and clinicians use the wireless monitoring system during intervention periods and current standard of care (i.e., manual vital sign measurement when clinically indicated) during control periods. Our primary outcome for effectiveness is a composite of severe maternal outcomes per World Health Organization criteria (e.g. death, cardiac arrest, jaundice, shock, prolonged unconsciousness, paralysis, hysterectomy). Secondary outcomes include maternal mortality rate, and case fatality rates for postpartum hemorrhage, hypertensive disorders, and sepsis. We will use the RE-AIM implementation framework to measure implementation metrics of the wireless physiologic system including Reach (proportion of eligible women monitored, length of time women monitored), Efficacy (proportion of women with monitoring according to Uganda Ministry of Health guidelines, number of appropriate alerts sent), Adoption (proportion of clinicians utilizing physiologic data per shift, clinical actions in response to alerts), Implementation (fidelity to monitoring protocol), Maintenance (sustainability of implementation over time). We will also perform in-depth qualitative interviews with up to 30 women and 30 clinicians participating in the study. DISCUSSION: This is the first hybrid-effectiveness study of wireless physiologic monitoring in an obstetric population. This study offers insights into use of wireless monitoring systems in low resource-settings, as well as normal and abnormal physiologic parameters among women delivering by cesarean. TRIAL REGISTRATION: ClinicalTrials.gov , NCT04060667 . Registered on 08/01/2019.

Entities:  

Keywords:  Cesarean delivery; Hybrid effectiveness-implementation trial; Maternal mortality; Post-operative monitoring; Wireless physiologic monitoring

Mesh:

Year:  2021        PMID: 33579213      PMCID: PMC7880025          DOI: 10.1186/s12884-021-03550-w

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.007


  45 in total

1.  Maternal near miss--towards a standard tool for monitoring quality of maternal health care.

Authors:  Lale Say; João Paulo Souza; Robert C Pattinson
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2009-03-19       Impact factor: 5.237

2.  Applying the RE-AIM framework to assess the public health impact of policy change.

Authors:  Stephanie Jilcott; Alice Ammerman; Janice Sommers; Russell E Glasgow
Journal:  Ann Behav Med       Date:  2007-10

Review 3.  The postpartum period: the key to maternal mortality.

Authors:  X F Li; J A Fortney; M Kotelchuck; L H Glover
Journal:  Int J Gynaecol Obstet       Date:  1996-07       Impact factor: 3.561

4.  Saving mothers' lives. Reviewing maternal deaths to make motherhood safer: 2006-2008.

Authors:  Helen Wilkinson
Journal:  BJOG       Date:  2011-10       Impact factor: 6.531

Review 5.  Maternal early warning systems.

Authors:  Alexander M Friedman
Journal:  Obstet Gynecol Clin North Am       Date:  2015-06       Impact factor: 2.844

Review 6.  The RE-AIM framework: a systematic review of use over time.

Authors:  Bridget Gaglio; Jo Ann Shoup; Russell E Glasgow
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

Review 7.  Maternal mortality: who, when, where, and why.

Authors:  Carine Ronsmans; Wendy J Graham
Journal:  Lancet       Date:  2006-09-30       Impact factor: 79.321

Review 8.  Beyond too little, too late and too much, too soon: a pathway towards evidence-based, respectful maternity care worldwide.

Authors:  Suellen Miller; Edgardo Abalos; Monica Chamillard; Agustin Ciapponi; Daniela Colaci; Daniel Comandé; Virginia Diaz; Stacie Geller; Claudia Hanson; Ana Langer; Victoria Manuelli; Kathryn Millar; Imran Morhason-Bello; Cynthia Pileggi Castro; Vicky Nogueira Pileggi; Nuriya Robinson; Michelle Skaer; João Paulo Souza; Joshua P Vogel; Fernando Althabe
Journal:  Lancet       Date:  2016-09-16       Impact factor: 79.321

9.  Effect of a novel vital sign device on maternal mortality and morbidity in low-resource settings: a pragmatic, stepped-wedge, cluster-randomised controlled trial.

Authors:  Nicola Vousden; Elodie Lawley; Hannah L Nathan; Paul T Seed; Muchabayiwa Francis Gidiri; Shivaprasad Goudar; Jane Sandall; Lucy C Chappell; Andrew H Shennan
Journal:  Lancet Glob Health       Date:  2019-03       Impact factor: 26.763

10.  Detection of physiological deterioration by the SNAP40 wearable device compared to standard monitoring devices in the emergency department: the SNAP40-ED study.

Authors:  Matthew J Reed; Megan McGrath; Polly L Black; Steff Lewis; Christopher McCann; Stewart Whiting; Rachel O'Brien; Alison Grant; Beth Harrison; Laura Skyrme; Miranda Odam
Journal:  Diagn Progn Res       Date:  2018-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.